Rifabutin

"Rifabutin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.

Descriptor ID

D017828

MeSH Number(s)

D03.549.811.650

D04.345.295.750.650

Concept/Terms

Below are MeSH descriptors whose meaning is more general than "Rifabutin".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds with 4 or More Rings [D03.549]
Rifamycins [D03.549.811]
Rifabutin [D03.549.811.650]
Polycyclic Compounds [D04]
Macrocyclic Compounds [D04.345]
Lactams, Macrocyclic [D04.345.295]
Rifamycins [D04.345.295.750]
Rifabutin [D04.345.295.750.650]

Below are MeSH descriptors whose meaning is related to "Rifabutin".

Below are MeSH descriptors whose meaning is more specific than "Rifabutin".

Rifabutin
Streptovaricin

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Rifabutin" by people in Harvard Catalyst Profiles by year, and whether "Rifabutin" was a major or minor topic of these publication.

Bar chart showing 29 publications over 17 distinct years, with a maximum of 4 publications in 1992 and 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	0	4	4
1994	1	0	1
1995	1	0	1
1996	1	1	2
1997	1	1	2
1998	0	1	1
1999	0	2	2
2001	0	1	1
2002	0	1	1
2003	2	2	4
2004	1	1	2
2005	2	0	2
2006	1	0	1
2008	0	1	1
2014	0	1	1
2019	2	0	2
2021	0	1	1

Below are the most recent publications written about "Rifabutin" by people in Profiles.

Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART. J Antimicrob Chemother. 2021 02 11; 76(3):710-717.

View in: PubMed
Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART. J Antimicrob Chemother. 2019 09 01; 74(9):2707-2715.

View in: PubMed
Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates. J Antimicrob Chemother. 2019 06 01; 74(6):1477-1483.

View in: PubMed
Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2017 12; 33(12):1202-1204.

View in: PubMed
Successful rifampin desensitization in a pediatric patient with latent tuberculosis. Pediatr Allergy Immunol. 2014 Jun; 25(4):404-5.

View in: PubMed
Studies toward total synthesis of divergolides C and D. Org Lett. 2013 Apr 05; 15(7):1736-9.

View in: PubMed
Flow-dependent regulation of angiopoietin-2. J Cell Physiol. 2008 Feb; 214(2):491-503.

View in: PubMed
Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels. J Biol Chem. 2008 Mar 21; 283(12):7674-81.

View in: PubMed
Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT. . 2006 May; 5(5):1197-208.

View in: PubMed
17-AAG: mechanisms of antitumour activity. Expert Opin Investig Drugs. 2005 Dec; 14(12):1471-4.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Biol Chem
J Antimicrob Chemother
Clin Pharmacol Ther
Blood
J Immunol
Cancer Res
Arterioscler Thromb Vasc Biol
Arch Ophthalmol
Am J Ophthalmol